Hrt Financial LP Sorrento Therapeutics, Inc. Transaction History

Hrt Financial LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $355,974 - $560,590	-56,059 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.03 - $16.51 $305,776 - $718,118	43,496 Added 346.22%	56,059 $463,000
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $72,362 - $150,127	12,563 New	12,563 $85,000
Q1 2020 May 15, 2020	SELL	$1.57 - $4.76 $169,453 - $513,756	-107,932 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.45 - $4.17 $135,617 - $390,015	93,529 Added 649.37%	107,932 $364,000
Q3 2019 Nov 14, 2019	BUY	$2.05 - $2.69 $29,526 - $38,744	14,403 New	14,403 $30,000
Q2 2019 Aug 14, 2019	SELL	$2.67 - $4.38 $40,984 - $67,233	-15,350 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$1.86 - $5.94 $28,551 - $91,179	15,350 New	15,350 $72,000
Q4 2018 Feb 15, 2019	SELL	$2.01 - $4.24 $90,311 - $190,507	-44,931 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$4.22 - $7.5 $189,608 - $336,982	44,931 New	44,931 $197,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.